Legato Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,577
| Closed | -$206K | – | 564 |
|
|
2023
Q4 | $206K | Buy |
+6,577
| New | +$206K | 0.03% | 526 |
|
|
2018
Q1 | – | Sell |
-29,432
| Closed | -$886K | – | 124 |
|
|
2017
Q4 | $886K | Sell |
29,432
-4,316
| -13% | -$130K | 0.13% | 155 |
|
|
2017
Q3 | $1.27M | Buy |
33,748
+25,748
| +322% | +$970K | 0.19% | 133 |
|
|
2017
Q2 | $223K | Buy |
+8,000
| New | +$223K | 0.1% | 187 |
|